Skip to main content
main-content

Axel S Merseburger MD

Prof. Dr. med. Axel S. Merseburger is the chairman of the Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Germany. Professor Merseburger obtained his medical degree from Hannover Medical School in 2002 after a one-year academic research programme in Washington DC, USA, where he completed his MD thesis. In 2008, he accepted a staff position in Hannover and was promoted to associate professor in 2009; he obtained full professorship in 2012.

Professor Merseburger is board certified in urology and is a member of numerous national and international urological and oncological associations. In addition to serving as a reviewer and member of the editorial board of many journals, Professor Merseburger is the associate editor of the World Journal of Urology and Editor-in-Chief of the “Advanced Prostate Cancer Resource Centre”. Furthermore, he is a member of the European Association of Urology (EAU) Guideline Groups on Renal Cell Cancer. He serves as national and international principal investigator in several phase II/III clinical trials.

Professor Merseburger has won multiple awards, stipends and prizes for his molecular and clinical research and has authored and co-authored more that 200 publications.

Latest contributions from Axel Merseburger

01-06-2019 | Castration-sensitive prostate cancer | ASCO 2019 | Article

Researcher comment: Apalutamide addition improves metastatic CSPC survival

Study author Axel Merseburger takes us through the TITAN trial investigating the addition of apalutamide to androgen deprivation therapy in the metastatic castration-sensitive prostate cancer setting, and also addresses the key question of how physicians should choose between the available treatment options (3:03).

16-03-2018 | Axel S Merseburger | Article

Advisory board comment

Comment on: EBRT plus brachytherapy stands out for high-risk prostate cancer

28-04-2017 | Genitourinary cancers | Conference report | Article

Highlights from the 2017 Genitourinary Cancer Symposium (ASCO-GU), Orlando, Florida, USA

Advisory Board member Prof Axel Merseburger discusses the key outcomes from the 2017 ASCO-GU Congress in Orlando, Florida.

Image Credits